menu search

EVH / Evolent Health, Inc. (EVH) Q1 2023 Earnings Call Transcript

Evolent Health, Inc. (EVH) Q1 2023 Earnings Call Transcript
Evolent Health, Inc. (NYSE:EVH ) Q1 2023 Results Conference Call May 3, 2023 5:00 PM ET Company Participants Seth Frank - VP, IR Seth Blackley - CEO John Johnson - CFO Conference Call Participants Sandy Draper - Guggenheim Partners Anne Samuel - JP Morgan Charles Rhyee - TD Cowen David Larsen - BTIG Jailendra Singh - Truist Jeff Garro - Stephens Jessica Tassan - Piper Sandler Richard Close - Canaccord Genuity Ryan Daniels - William Blair Sean Dodge - RBC Capital Markets Operator Welcome to Evolent Health's Earnings Conference Call for the Quarter Ended March 31, 2023. As a reminder, this conference call is being recorded. Read More
Posted: May 3 2023, 22:50
Author Name: Seeking Alpha
Views: 112171

EVH News  

Evolent Health, Inc. (EVH) Q3 2023 Earnings Call Transcript

By Seeking Alpha
November 4, 2023

Evolent Health, Inc. (EVH) Q3 2023 Earnings Call Transcript

Evolent Health, Inc. (NYSE:EVH ) Q3 2023 Earnings Conference Call November 2, 2023 5:00 PM ET Company Participants Seth Frank - Vice President, Invest more_horizontal

Evolent Health (EVH) Surpasses Q3 Earnings and Revenue Estimates

By Zacks Investment Research
November 2, 2023

Evolent Health (EVH) Surpasses Q3 Earnings and Revenue Estimates

Evolent Health (EVH) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to ea more_horizontal

Evolent to release third quarter financial results on Thursday, Nov. 2, 2023, and participate in upcoming investor conferences

By PRNewsWire
October 10, 2023

Evolent to release third quarter financial results on Thursday, Nov. 2, 2023, and participate in upcoming investor conferences

WASHINGTON , Oct. 10, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with comp more_horizontal

Evolent Health (EVH) Moves to Buy: Rationale Behind the Upgrade

By Zacks Investment Research
October 5, 2023

Evolent Health (EVH) Moves to Buy: Rationale Behind the Upgrade

Evolent Health (EVH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive more_horizontal

A First Evaluation On Evolent Health

By Seeking Alpha
October 4, 2023

A First Evaluation On Evolent Health

Evolent Health, Inc., is a mid-cap solutions provider in the healthcare space that made a major acquisition late last year. The stock is down some 30% more_horizontal

Evolent Health, Inc. (EVH) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 2, 2023

Evolent Health, Inc. (EVH) Q2 2023 Earnings Call Transcript

Evolent Health, Inc. (NYSE:EVH ) Q2 2023 Earnings Conference Call August 2, 2023 5:00 PM ET Company Participants Seth Frank – Vice President-Investo more_horizontal

Evolent Health: Business Economics Still Appealing, Reiterate Buy

By Seeking Alpha
July 19, 2023

Evolent Health: Business Economics Still Appealing, Reiterate Buy

Evolent Health's sales and profitability are creeping back above pre-pandemic levels. The company's recent acquisitions have added incremental value, more_horizontal

Evolent Health, Inc. (EVH) Q1 2023 Earnings Call Transcript

By Seeking Alpha
May 3, 2023

Evolent Health, Inc. (EVH) Q1 2023 Earnings Call Transcript

Evolent Health, Inc. (NYSE:EVH ) Q1 2023 Results Conference Call May 3, 2023 5:00 PM ET Company Participants Seth Frank - VP, IR Seth Blackley - CEO J more_horizontal


Search within

Pages Search Results: